Abstract
Background and importanceIn order to ensure the sustainability of the French healthcare system, the government launched two incentives to increase biosimilar use in August 2018, within the framework of the...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
